Management of peripheral lymph node tuberculosis in routine practice: An unselected 10-year cohort

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 3, 2011, Pages 375-378

  Blaikley, J F ^a   Khalid, S ^a   Ormerod, L P ^a,b  

^a ROYAL BLACKBURN HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

Extra pulmonary tuberculosis; Lymph node; Treatment

Indexed keywords

CIPROFLOXACIN; CORTICOSTEROID; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ABSCESS; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ASPIRATION BIOPSY; AXILLARY LYMPH NODE; BACTERIUM CULTURE; CERVICAL LYMPH NODE; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG FATALITY; FEMALE; HUMAN; HUMAN TISSUE; INGUINAL LYMPH NODE; LUNG EMBOLISM; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; PRIORITY JOURNAL; SHORT COURSE THERAPY; TREATMENT DURATION; TUBERCULOUS LYMPHADENITIS; UNITED KINGDOM;

ADULT; ANTITUBERCULAR AGENTS; BIOPSY; BIOPSY, FINE-NEEDLE; DATABASES, FACTUAL; ENGLAND; FEMALE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, LYMPH NODE; WALES;

EID: 79951658681     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Six-months versus nine-months chemotherapy for tuberculosis of lymph nodes: preliminary results. British Thoracic Society Research Committee. Respir Med 1992; 86: 15-19.
2. Campbell I A, Ormerod L P, Friend J A, Jenkins P A, Prescott R J. Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results. Respir Med 1993; 87: 621-623. (Pubitemid 23350171)
3. Short course chemotherapy for tuberculosis of lymph nodes: a controlled trial. British Thoracic Society Research Committee. BMJ (Clin Res Ed) 1985; 290: 1106-1108.
4. Short-course chemotherapy for lymph node tuberculosis: final report at 5 years. British Thoracic Society Research Committee. Br J Dis Chest 1988; 82: 282-284.
5. Lenfant C. Shattuck Lecture: clinical research to clinical practice -lost in translation? N Engl J Med 2003; 349: 868-874.
6. National survey of tuberculosis notifications in England and Wales in 1983: characteristics of disease. Report from the Medical Research Council Tuberculosis and Chest Diseases Unit. Tubercle 1987; 68: 19-32.
7. Tuberculosis in the UK: annual report on tuberculosis surveillance in the UK, 2009. London, UK: Health Protection Agency for Infections, 2009.
8. Ormerod L P. Chemotherapy of tuberculosis. Eur Respir Monogr 1997; 2: 273-297. (Pubitemid 27359547)
9. Ormerod L P, Horsfield N, Green R M. Tuberculosis treatment outcome monitoring: Blackburn 1988-2000. Int J Tuberc Lung Dis 2002; 6: 662-665.
10. Sachdeva R, Gadre D V, Talwar V. Characterisation and drug susceptibility patterns of extra-pulmonary mycobacterial isolates. Indian J Med Res 2002; 115: 102-107.
11. Yang H, Field S K, Fisher D A, Cowie R L. Tuberculosis in Calgary, Canada, 1995-2002: site of disease and drug susceptibility. Int J Tuberc Lung Dis 2005; 9: 288-293.
12. Diez M, Huerta C, Moreno T, et al. Tuberculosis in Spain: epidemiological pattern and clinical practice. Int J Tuberc Lung Dis 2002; 6: 295-300. (Pubitemid 34263685)
13. Bonadio M, Carpi A, Gigli C, Virgone E, Carneglia L. Epidemiological and clinical features of 139 patients with tuberculosis at a teaching hospital in Italy (Pisa, 1996-2000). Biomed Pharmacother 2005; 59: 127-131.
14. Hasibi M, Rezaii J, Kermani Z M, et al. The need to reassess the value of fine needle aspiration in the diagnosis of tuberculous cervical lymphadenitis in Iran. Scand J Infect Dis 2007; 39: 750-751. (Pubitemid 47180484)
15. Menon K, Bem C, Gouldesbrough D, Strachan D R. A clinical review of 128 cases of head and neck tuberculosis presenting over a 10-year period in Bradford, UK. J Laryngol Otol 2007; 121: 362-368. (Pubitemid 46714679)
16. Nayak S, Puranik S C, Deshmukh S D, et al. Fine-needle aspiration cytology in tuberculous lymphadenitis of patients with and without HIV infection. Diagn Cytopathol 2004; 31: 204-206. (Pubitemid 39314814)
17. Ormerod L P, Harrison J M, Wright P A. Drug resistance in Mycobacterium tuberculosis: a survey over 25 years in Black-burn. Thorax 1986; 41: 946-950.
18. Ormerod L P, Green R M, Horsfield N, White R. Drug resistance trends in M. tuberculosis: Blackburn 1990-1999. Int J Tuberc Lung Dis 2001; 5: 903-905.
19. Roberts D S, Dowdall J R, Winter L, et al. Cervical tuberculosis: a decision tree for protecting healthcare workers. Laryngoscope 2008; 118: 1345-1349.
20. Golden M P, Vikram H R. Extra-pulmonary tuberculosis: an overview. Am Fam Physician 2005; 72: 1761-1768.
21. Prasad K C, Sreedharan S, Chakravarthy Y, Prasad S C. Tuberculosis in the head and neck: experience in India. J Laryngol Otol 2007; 121: 979-985. (Pubitemid 351650447)
22. Breen R A, Smith C J, Bettinson H, et al. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax 2004; 59: 704-707. (Pubitemid 39061536)
23. Cagatay A A, Caliskan Y, Aksoz S, et al. Extra-pulmonary tuberculosis in immunocompetent adults. Scand J Infect Dis 2004; 36: 799-806.
24. Chest Service, Medical and Health Department. Annual report 1990. Hong Kong, SAR China: Hong Kong Government, 1990.
25. Rose A M, Gatto A J, Watson J M. Recent increases in tuberculosis notifications in England and Wales - real or artefact? J Public Health Med 2002; 24: 136-137.